Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

AMAG gets FDA warning for misbranding drugs

October 27, 2010 12:34 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

The FDA has sent a letter to the CEO of AMAG Pharmaceuticals Inc., warning the company that websites promoting two FDA-approved products omit information about risks associated with the drug products.

Prostate Oncology Specialists Among First in the Nation to Treat Advanced Prostate Cancer Patients With PROVENGE

October 27, 2010 12:34 pm | by Bio-Medicine.Org | News | Comments

MARINA DEL REY, Calif., Oct. 27 /- Prostate Oncology Specialists, Inc. of Marina del Rey is among the first sites in the nation to treat advanced prostate cancer patients with PROVENGE® (sipuleucel-T), the first in a new therapeutic class known as autologous cellular immunotherapies....

TOPICS:

Abbott Statement: Abbott Provides Support for Cholera Relief Efforts in Haiti

October 27, 2010 12:34 pm | by Bio-Medicine.Org | News | Comments

Haiti relief efforts build on Abbott's existing philanthropic partnerships to expand access to health care in the country.  Since 2007, Abbott and the Abbott Fund have provided more than $34 million in grants and product donations to help address health needs in Haiti, including...

TOPICS:
Advertisement

Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs

October 27, 2010 12:33 pm | by Bio-Medicine.Org | News | Comments

EAST NORRITON, Pa., Oct. 27 /- Tengion, Inc. (Nasdaq: TNGN ), a leader in regenerative medicine, reviewed pipeline progress at its first Analyst and Investor Meeting which was held today in New York City.  The event featured updates and discussions of milestones and key data for the...

TOPICS:

Founder of Northstar Healthcare takes control, returns as chief executive

October 27, 2010 11:45 am | by The Associated Press | News | Comments

The founder and first chief executive of Northstar Healthcare Inc. (TSX:NHC) is returning, having recently acquired a majority ownership stake in the company. Donald Kramer will be Northstar's CEO, replacing Steve Linehan who is leaving the company. Northstar owns or manages surgical centres in...

GTC Biotherapeutics makes a profit by regaining ATryn drug rights

October 27, 2010 10:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

GTC Biotherapeutics Inc. reported a profit of $3.5 million for the third quarter of 2010, compared with a loss of $5.1 million, or 48 cents per share, for the third quarter of 2009.

TOPICS:

Supply Chain Efficiency Was Key Factor in Driving Profits for Manufacturers and Service Providers During Down Economy

October 27, 2010 10:36 am | by Material Handling Industry of America | News | Comments

Amid economic turmoil, businesses rely on the efficiency of supply chain operations to respond to consumer demand for lower prices and the ability to maintain profits, as indicated by the eighth annual "Global Survey of Supply Chain Progress."

GlaxoSmithKline Applauds North Carolina's Child Advocates

October 27, 2010 10:35 am | by Bio-Medicine.Org | News | Comments

WILMINGTON, N.C., Oct. 27 /- North Carolina's public health professionals today were honored with GlaxoSmithKline Child Health Recognition Awards for improving children's health through a variety of programs, including school health nurses, nutrition education, immunizations and better...

TOPICS:
Advertisement

Paragon Bioservices Launches Second Expansion to Celebrate its 20th Anniversary

October 27, 2010 10:35 am | by Bio-Medicine.Org | News | Comments

BALTIMORE, Oct. 27 /- Paragon Bioservices, a Baltimore-based CMO focused on the contract research, process development and manufacturing of biologics, announced today that the company will celebrate its 20th anniversary in November by undergoing a second expansion of facilities at the...

TOPICS:

As Pharmaceutical Supply Chain Goes Global, Threat of Counterfeiting, Intellectual Property Theft and Contamination Rises, Finds New Report; New Supply Chain Management Strate...

October 27, 2010 10:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Oct. 27 /- Global pharmaceutical outsourcing has become increasingly prevalent, but is creating a complex and risky supply chain environment that has pharmaceutical and life sciences executives on high alert, according to a major study co-sponsored by PwC US and published today...

TOPICS:

Laureate Pharma Announces New Development and Manufacturing Agreement to Produce AVEO Pharmaceuticals' Antibody Therapeutic

October 27, 2010 10:35 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., Oct. 27 /- Laureate Pharma, Inc., a full-service contract development and manufacturing organization, announced today that they have entered into a development and manufacturing agreement to produce AV-203, AVEO Pharmaceutical's (Cambridge, MA) novel monoclonal antibody...

TOPICS:

Essential Pharmaceuticals Acquires Exclusive Worldwide Rights to Family of Cell Media Products from Lifeblood Medical

October 27, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

NEWTOWN, Pa., Oct. 27 /- Essential Pharmaceuticals, LLC, a private company dedicated to providing specialty reagents and solutions to the life sciences market, announced today that the Company will commence sales and distribution of three distinct animal-component-free products: serum...

TOPICS:

Nanoshells provide golden 'touch' in killing breast tumors

October 27, 2010 10:34 am | by Baylor College of Medicine | News | Comments

Using tiny gold "nanoshells" to deliver just a little heat to breast tumor cells already treated with radiation boosts the killing potential of the treatment – not just shrinking the tumor but killing the cancer stem cells, said researchers at Baylor College of Medicine , The...

TOPICS:

Samplify's New Medical Ultrasound Development Kit Accelerates Equipment Time to Market By Up to 12 Months

October 27, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

SANTA CLARA, Calif., Oct. 27 /- Samplify Systems, Inc., a leading provider of innovative beamforming technology, analog-front-end semiconductors and solutions for the medical imaging market, today introduces its new SMK9130 Ultrasound Beamforming Development Kit.  Based on Samplify's...

TOPICS:

InVivo Therapeutics raises $10.5M, completes reverse merger

October 27, 2010 10:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

InVivo Therapeutics Corp., a Cambridge spinal cord injury treatment developer, has completed a reverse merger and initiated a $10.5 million private placement offering.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading